HASSAMAL: Department of Addiction Psychiatry, UCLA Kern, Bakersfield, CA
GOLDENBERG: Department of Addiction Psychiatry, UCLA San Fernando Valley/VA Greater Los Angeles, Sepulveda, CA
ISHAK: Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, CA, and David Geffen School of Medicine at UCLA, Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
HAGLUND and DANOVITCH: Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, CA
MIOTTO: David Geffen School of Medicine at UCLA, Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
The authors declare no conflicts of interest.
Please send correspondence to: Sameer Hassamal, MD, Department of Addiction Psychiatry, UCLA Kern, 1700 Mount Vernon Avenue, Bakersfield, CA 93306 (e-mail: [email protected]).